Getinge acquires distributor in Ireland:
This article was originally published in Clinica
Executive Summary
Swedish company Getinge Industrier has bought its distributor, Lenken Healthcare (Ireland). The company, with turnover of around $10 million and 58 employees, has sales offices in Belfast and Dublin. Lenken has sold Getinge's patient handling and anti-decubitis products, as well as its hygiene system, in Ireland for 20 years. The Getinge-based company plans to focus on improving market share in the Republic of Ireland; it already has over 50% share in Northern Ireland.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.